Literature DB >> 4745430

Protein and fatty acid composition of mesosomal vesicles and plasma membranes of Staphylococcus aureus.

T S Theodore, C Panos.   

Abstract

Qualitatively, the protein and fatty acid composition of purified mesosomal vesicles and the plasma membrane isolated from Staphylococcus aureus ATCC 6538P are identical, the major difference between these two cellular components being only quantitative in nature. Mesosomal vesicles and plasma membranes, when subjected to acidic or neutral disk gel electrophoresis, exhibited more than 22 bands of protein. With urea-acetic acid gels, the plasma membrane had a higher concentration of "slower-migrating proteins" whereas "faster-migrating proteins" predominated in the mesosomal vesicles. With neutral disk gel electrophoresis, mesosomal vesicles exhibited one prominent protein band with an approximate molecular weight of 35,000 and which was four times greater than that found in the corresponding region on gels of the plasma membrane. Finally, fatty acid analyses by capillary column gas chromatography showed that although the fatty acid composition is the same, the fatty acid content in mesosomal vesicles is 48% greater than that of the plasma membrane. The dominant fatty acids in both of these cellular components are the iso and anteiso branched methyl C15, C17, and C19 fatty acids and comprise at least 85% of the total fatty acids extracted. These results show that distinct chemical differences exist between the mesosomal vesicles and the plasma membrane of Staphylococcus aureus.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4745430      PMCID: PMC285419          DOI: 10.1128/jb.116.2.571-576.1973

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  19 in total

1.  Fractionation and characterization of the plasma and mesosome membrane of Listeria monocytogenes.

Authors:  B K Ghosh; R G Murray
Journal:  J Bacteriol       Date:  1969-01       Impact factor: 3.490

2.  A detergent-polyacrylamide gel system for electrophoretic resolution of membrane and wall proteins.

Authors:  E A Grula; C F Savoy
Journal:  Biochem Biophys Res Commun       Date:  1971-04-16       Impact factor: 3.575

Review 3.  Structure and function of bacterial cell membranes.

Authors:  M R Salton
Journal:  Annu Rev Microbiol       Date:  1967       Impact factor: 15.500

4.  Fractionation of isolated bacterial membranes.

Authors:  M R Salton; M D Schmitt; P E Trefts
Journal:  Biochem Biophys Res Commun       Date:  1967-12-15       Impact factor: 3.575

5.  The isolation and characterisation of cytoplasmic membranes and mesosomes of Bacillus licheniformis 6346.

Authors:  D A Reaveley
Journal:  Biochem Biophys Res Commun       Date:  1968-03-27       Impact factor: 3.575

6.  Lipid alterations after cell wall inhibition. Fatty acid content of Streptococcus pyogenes and derived L-form.

Authors:  C Panos; M Cohen; G Fagan
Journal:  Biochemistry       Date:  1966-05       Impact factor: 3.162

7.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

8.  Fatty acid interconversions in Mycoplasma sp. KHS.

Authors:  C Panos; C V Henrikson
Journal:  Biochemistry       Date:  1969-02       Impact factor: 3.162

9.  Fatty acid composition of the complex lipids of Staphylococcus aureus during the formation of the membrane-bound electron transport system.

Authors:  D C White; F E Frerman
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490

10.  Extraction, characterization, and cellular localization of the lipids of Staphylococcus aureus.

Authors:  D C White; F E Frerman
Journal:  J Bacteriol       Date:  1967-12       Impact factor: 3.490

View more
  12 in total

Review 1.  Mesosomes: membranous bacterial organelles.

Authors:  J W Greenawalt; T L Whiteside
Journal:  Bacteriol Rev       Date:  1975-12

2.  Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.

Authors:  Raquel Regina Bonelli; Tanja Schneider; Hans-Georg Sahl; Imke Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

3.  Nuclear and cell division in Bacillus subtilis: dormant nucleoids in stationary-phase cells and their activation.

Authors:  W Van Iterson; P A Michels; F Vyth-Dreese; J A Aten
Journal:  J Bacteriol       Date:  1975-03       Impact factor: 3.490

4.  Biochemical and genetic basis of tetracycline resistance in Staphylococcus aureus.

Authors:  I Chopra; R W Lacey; J Connolly
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

5.  Fatty acid composition of selected prosthecate bacteria.

Authors:  R N Carter; J M Schmidt
Journal:  Arch Microbiol       Date:  1976-10-11       Impact factor: 2.552

6.  Characterization of the lipids of mesosomal vesicles and plasma membranes from Staphylococcus aureus.

Authors:  P R Beining; E Huff; B Prescott; T S Theodore
Journal:  J Bacteriol       Date:  1975-01       Impact factor: 3.490

7.  Oritavancin binds to isolated protoplast membranes but not intact protoplasts of Staphylococcus aureus.

Authors:  Sung Joon Kim; Manmilan Singh; Jacob Schaefer
Journal:  J Mol Biol       Date:  2009-06-16       Impact factor: 5.469

8.  Lipoteichoic acid localization in mesosomal vesicles of Staphylococcus aureus.

Authors:  E Huff; R M Cole; T S Theodore
Journal:  J Bacteriol       Date:  1974-10       Impact factor: 3.490

9.  Comparative genome-scale modelling of Staphylococcus aureus strains identifies strain-specific metabolic capabilities linked to pathogenicity.

Authors:  Emanuele Bosi; Jonathan M Monk; Ramy K Aziz; Marco Fondi; Victor Nizet; Bernhard Ø Palsson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-10       Impact factor: 11.205

Review 10.  Applications of cellular fatty acid analysis.

Authors:  D F Welch
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.